Shopping Cart
Remove All
Your shopping cart is currently empty
Landogrozumab (LY2495655) is a humanized anti-Growth Differentiation Factor-8 (GDF-8) monoclonal antibody that improves muscle size and may be used to study cancer and neurological disorders.

| Description | Landogrozumab (LY2495655) is a humanized anti-Growth Differentiation Factor-8 (GDF-8) monoclonal antibody that improves muscle size and may be used to study cancer and neurological disorders. |
| In vivo | Landogrozumab administered as a single intravenous injection at doses of 3 mg/kg and 15 mg/kg affected muscle mass in aged mice with Duchenne muscular dystrophy. [1] |
| Synonyms | LY2495655, LY 2495655, Anti-GDF8 / Myostatin Reference Antibody |
| Reactivity | Human |
| Application | FACS Functional assay |
| Antibody Type | Monoclonal |
| Endotoxin | < 1.0 EU/mg |
| Conjucates | Unconjugated |
| Uniprot ID |
| Cas No. | 1391726-30-9 |
| Color | Transparent |
| Appearance | Liquid |
| Isotype | IgG4 |
| Recommended Isotype Control |
| Storage | store at low temperature | -20°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.